Pharma-Bio Serv, Inc. (PBSV)
OTCMKTS: PBSV · Delayed Price · USD
0.847
+0.047 (5.87%)
Mar 27, 2024, 1:08 PM EDT - Market open
Pharma-Bio Serv Balance Sheet
Financials in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2005 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 10.45 | 14.46 | 17.47 | 17.14 | 15.49 | 16.03 | 11.75 | 13.77 | 14.89 | 15.09 | Upgrade
|
Short-Term Investments | 4.53 | 0 | 0 | 0 | 0 | 0.04 | 0.03 | 0.02 | 0.03 | 0.07 | Upgrade
|
Cash & Cash Equivalents | 14.98 | 14.46 | 17.47 | 17.14 | 15.49 | 16.07 | 11.78 | 13.79 | 14.93 | 15.16 | Upgrade
|
Cash Growth | 3.56% | -17.21% | 1.93% | 10.64% | -3.63% | 36.47% | -14.61% | -7.59% | -1.51% | 25.08% | Upgrade
|
Receivables | 3.94 | 4.98 | 4.61 | 10.98 | 10.03 | 6.94 | 7.21 | 6.85 | 7.45 | 6.39 | Upgrade
|
Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Other Current Assets | 0.48 | 0.5 | 0.74 | 0.47 | 0.45 | 0.39 | 0.55 | 0.98 | 0.89 | 0.78 | Upgrade
|
Total Current Assets | 19.4 | 19.94 | 22.82 | 28.58 | 25.97 | 23.41 | 19.54 | 21.63 | 23.27 | 22.32 | Upgrade
|
Property, Plant & Equipment | 0.39 | 0.58 | 0.75 | 1.06 | 0.29 | 0.3 | 2.39 | 2.33 | 0.85 | 0.87 | Upgrade
|
Long-Term Investments | 4,527 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Other Long-Term Assets | -4,526.52 | 0.13 | 0.35 | 0.27 | 0.37 | 1.67 | 0.42 | 0.04 | 0.02 | 0.02 | Upgrade
|
Total Long-Term Assets | 0.5 | 0.71 | 1.1 | 1.33 | 0.66 | 1.97 | 2.81 | 2.37 | 0.87 | 0.89 | Upgrade
|
Total Assets | 19.9 | 20.65 | 23.92 | 29.92 | 26.63 | 25.38 | 22.35 | 24 | 24.14 | 23.21 | Upgrade
|
Accounts Payable | 1.47 | 1.63 | 2.07 | 1.94 | 1.59 | 2.14 | 1.53 | 2.09 | 2.06 | 2.36 | Upgrade
|
Deferred Revenue | -2,000.67 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Current Debt | 0.15 | 0.14 | 0.13 | 1.46 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | Upgrade
|
Other Current Liabilities | 2,001 | 0.34 | 0.45 | 0.39 | 2.07 | 0.41 | 0 | 0.04 | 0.04 | 0.25 | Upgrade
|
Total Current Liabilities | 2.15 | 2.11 | 2.65 | 3.79 | 3.67 | 2.57 | 1.54 | 2.16 | 2.12 | 2.63 | Upgrade
|
Long-Term Debt | 0.19 | 0.35 | 0.49 | 1.33 | 0.07 | 0.05 | 0.06 | 0.03 | 0.05 | 0.07 | Upgrade
|
Other Long-Term Liabilities | 1.43 | 1.64 | 1.87 | 2.08 | 2.29 | 2.5 | 0 | 0 | 0 | 0 | Upgrade
|
Total Long-Term Liabilities | 1.62 | 1.99 | 2.36 | 3.41 | 2.36 | 2.55 | 0.06 | 0.03 | 0.05 | 0.07 | Upgrade
|
Total Liabilities | 3.78 | 4.09 | 5.01 | 7.2 | 6.03 | 5.11 | 1.6 | 2.19 | 2.18 | 2.7 | Upgrade
|
Total Debt | 0.35 | 0.49 | 0.62 | 2.79 | 0.08 | 0.06 | 0.07 | 0.05 | 0.07 | 0.1 | Upgrade
|
Debt Growth | -28.90% | -21.06% | -77.88% | 3474.08% | 30.63% | -18.92% | 41.95% | -30.49% | -22.74% | 15.28% | Upgrade
|
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Retained Earnings | 14.85 | 15.27 | 17.71 | 21.52 | 19.47 | 19.11 | 19.56 | 20.98 | 21.23 | 19.61 | Upgrade
|
Comprehensive Income | 0.21 | 0.24 | 0.14 | 0.16 | 0.14 | 0.11 | 0.14 | -0.17 | -0.23 | -0.14 | Upgrade
|
Shareholders' Equity | 16.13 | 16.56 | 18.91 | 22.72 | 20.61 | 20.26 | 20.75 | 21.81 | 21.96 | 20.51 | Upgrade
|
Total Liabilities and Equity | 19.9 | 20.65 | 23.92 | 29.92 | 26.63 | 25.38 | 22.35 | 24 | 24.14 | 23.21 | Upgrade
|
Net Cash / Debt | 14.63 | 13.98 | 16.85 | 14.35 | 15.41 | 16.01 | 11.7 | 13.74 | 14.85 | 15.06 | Upgrade
|
Net Cash / Debt Growth | 4.69% | -17.06% | 17.46% | -6.92% | -3.76% | 36.82% | -14.83% | -7.47% | -1.38% | 25.15% | Upgrade
|
Net Cash Per Share | 0.64 | 0.61 | 0.73 | 0.62 | 0.67 | 0.69 | 0.51 | 0.59 | 0.63 | 0.64 | Upgrade
|
Working Capital | 17.25 | 17.84 | 20.17 | 24.79 | 22.3 | 20.85 | 17.99 | 19.47 | 21.14 | 19.7 | Upgrade
|
Book Value Per Share | 0.70 | 0.72 | 0.82 | 0.99 | 0.89 | 0.88 | 0.90 | 0.95 | 0.95 | 0.89 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.